Credit Controller
Illumina
Credit Controller
Illumina
Develops sequencing platforms and consumables
Cambridge | Hub & Hybrid
At Illumina, every role contributes to something bigger. Our work helps advance scientific discoveries that improve human health, and behind that work are teams ensuring our customers and partners receive the support they need.
We’re looking for an experienced Italian-speaking Credit Controller to join our Accounts Receivable team in Cambridge. This is a hands-on opportunity for someone who knows credit control, enjoys building strong customer relationships and is confident working across customer portals to manage accounts, resolve issues and support timely payment.
The role is hub and hybrid, with the expectation of working from our Cambridge office one day per week, on Thursday, to collaborate with the onsite team.
For this opportunity, there are three key requirements:
You’ll support the Accounts Receivable function, helping to keep customer accounts accurate, payments moving and queries resolved. Your responsibilities will include:
You’ll also spend approximately 50% of your working time supporting testing activities for our Next Gen ERP project, giving you the opportunity to contribute to meaningful change alongside your core credit-control responsibilities.
The Illumina experience starts with our people: connected, collaborative and united by purpose. We work together because our achievements are shared.
Here, you’ll have the opportunity to own your work while collaborating across teams and building your experience through meaningful challenges. Whatever your role, your contribution is part of something bigger.
If you’re an experienced Credit Controller who speaks Italian, understands the end-to-end collections process and is confident navigating customer portals, we’d love to hear from you.
Bring your curiosity and make an impact.
Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.
Explore more opportunities at Illumina